Walleye Capital
TNYA icon

Walleye Capital’s Tenaya Therapeutics TNYA Stock Holding History

Walleye Capital’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-69,479
Closed -$134K – 5565
2024
Q3 		$134K Buy
+69,479
New +$196K ﹤0.01% 4258
2023
Q1 		– Sell
-203,929
Closed -$410K – 4370
2022
Q4 		$410K Buy
203,929
+125,704
+161% +$307K 0.01% 1574
2022
Q3 		$227K Buy
+78,225
New +$365K ﹤0.01% 2025

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Walleye Capital's TNYA Position: Q4 2024 in Review

Walleye Capital sold out of Tenaya Therapeutics (TNYA) in Q4 2024, closing a stake of 69,479 shares — an estimated $134K sold.

Walleye Capital first reported a position in TNYA in Q3 2022 and held it in 3 quarters. The position peaked at $410K in Q4 2022. 88 funds tracked by Wall St. Rank hold TNYA as of Q4 2024.

  • Walleye Capital reported no remaining Tenaya Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Walleye Capital sold 69,479 Tenaya Therapeutics shares in Q4 2024, an estimated $134K.
  • Walleye Capital first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 3 quarters.
  • Walleye Capital's Tenaya Therapeutics position peaked at $410K in Q4 2022.
  • 88 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.